FSMP，在某些市场常被称为“医疗食品”，是经过特殊加工的食品，用于在医疗监督下对患者进行饮食管理。它们不是普通食品、膳食补充剂或药品。1. 核心目的：它们旨在为因特定疾病、障碍或医疗状况（如吸收不良、代谢紊乱、术后恢复）而无法通过标准饮食满足营养需求的人群提供全面或针对性的营养。2. 监管状态与区别：在欧盟、英国和澳大利亚等关键市场，FSMP是一个独立的食品类别，受严格的成分和标签法规（如EU 609/2013）约束。它们与药品不同，因为其目的是管理营养摄入，而非治疗、治愈或预防疾病。在美国，类似的“医疗食品”类别由FDA根据《孤儿药法案》定义。3. 关键要求：医疗监督：一个基本原则是，其使用必须在医疗专业人员（医生、营养师或临床营养师）的监督下进行。它们通常通过药房、医院或凭处方/推荐获得。
FSMP, often referred to in some markets as “medical foods,” are specially processed foods formulated for the dietary management of patients under medical supervision. They are not ordinary foods, dietary supplements, or drugs. 1. Core Purpose They are designed to provide complete or targeted nutrition to individuals whose nutritional needs cannot be met by a standard diet due to specific diseases, disorders, or medical conditions (e.g., malabsorption, metabolic disorders, post-surgery recovery). 2. Regulatory Status & Distinction In key markets like the European Union, the UK, and Australia, FSMP are a distinct food category subject to strict compositional and labeling regulations (governed by regulations like EU 609\/2013). They differ from drugs as they are intended to manage nutritional intake, not to treat, cure, or prevent disease. In the United States, the analogous “medical food” category is defined by the FDA under the Orphan Drug Act. 3. Key Requirement: Medical Supervision A fundamental principle is that their use must be supervised by a healthcare professional (physician, dietitian, or clinical nutritionist). They are typically available through pharmacies, hospitals, or via prescription\/ recommendation.
特殊医学用途配方食品根据营养全面性和针对的具体健康状况进行分类。1. 全营养配方（标准型）：提供所有必需营养素，可作为唯一营养来源。例如，用于一般营养不良或吞咽困难患者的配方。2. 疾病特异性全营养配方：针对特定疾病的代谢需求定制的全营养配方，调整了特定营养素的水平（如蛋白质类型、碳水化合物来源、电解质含量）。常见类型包括：· 糖尿病（低升糖指数碳水化合物）· 慢性肾病（控制蛋白质、钾、磷）· 癌症（高蛋白、高能量，常含免疫营养素）· 先天性代谢缺陷（如不含苯丙氨酸的苯丙酮尿症配方）3. 营养组件（非全营养）：单一营养素或组合（如蛋白粉、脂肪乳剂、纤维混合物），用于补充膳食或其他配方，本身不提供全面营养。
FSMP are classified based on nutritional completeness and the specific health condition they address. 1. Complete Nutritional Formulas (Standard) These provide all essential nutrients and can serve as a sole source of nutrition. Examples include formulas for general malnutrition or for patients with swallowing difficulties (dysphagia). 2. Disease-Specific Complete Formulas These are complete formulas tailored for the distinct metabolic needs of a particular disease. They have modified levels of specific nutrients (e.g., protein type, carbohydrate source, electrolyte content). Common types include formulas for: · Diabetes (with low glycemic index carbohydrates) · Chronic Kidney Disease (with controlled protein, potassium, phosphorus) · Cancer (high-protein, high-energy, often with immune-nutrients) · Inborn Errors of Metabolism (e.g., PKU formulas lacking phenylalanine) 3. Nutritional Modules (Non-Complete) These are single nutrients or combinations (e.g., protein powders, fat emulsions, fiber mixes) used to supplement a diet or other formulas. They are not nutritionally complete on their own.
市场扩张受到医疗、人口和经济趋势的共同推动。1. 强有力的临床和经济证据：扎实的研究证明医学营养治疗能改善患者预后（减少并发症、缩短住院时间），从而为医疗系统节省总体成本，推动支付方和提供方的采用。2. 人口老龄化：全球老年人口快速增长，易患慢性疾病和营养不良，对专业营养支持产生持续的大规模需求。3. 慢性病患病率上升：全球癌症、糖尿病和肾脏疾病发病率上升，直接扩大了需要疾病特异性特殊医学用途配方食品的患者群体。4. 医疗服务模式演变：向家庭医疗和基于价值的护理模式转变，强调预防性管理和患者生活质量，使特殊医学用途配方食品成为门诊护理的关键工具。
The expansion is fueled by converging medical, demographic, and economic trends. 1. Strong Clinical and Economic Evidence Robust research proves that medical nutrition therapy improves patient outcomes (reduced complications, shorter hospital stays), leading to overall cost savings for healthcare systems. This drives adoption by payers and providers. 2. Aging Demographics The rapidly growing global elderly population is highly susceptible to chronic diseases and malnutrition, creating sustained, large-scale demand for specialized nutritional support. 3. Rising Chronic Disease Prevalence Increasing global rates of cancer, diabetes, and renal diseases directly expand the addressable patient population requiring disease-specific FSMP. 4. Evolution of Healthcare Delivery The shift towards home healthcare and value-based care models emphasizes preventive management and patient quality of life, positioning FSMP as key tools for outpatient care.
安全有效使用取决于知情实践和专业监督。1. 专业指导不可妥协：切勿自行处方。特殊医学用途配方食品必须在医生或注册营养师的持续监督下使用，由他们诊断营养缺乏、选择合适产品并确定剂量和疗程。2. 验证产品合法性：寻找明确标识为“特殊医学用途配方食品”（或“医疗食品”）的标签，并检查是否符合相关地区法规（如欧盟批准、美国FDA认可）。从信誉良好的来源购买，如药房或认证的家庭护理提供商。3. 针对病情选择：确保配方与具体医疗状况匹配。对肾脏疾病等使用标准配方可能有害。医疗专业人员会根据患者的诊断和化验结果进行选择。4. 依从与监测：精确遵循制备说明（水温、混合）以确保安全和营养素完整性。定期与医疗提供者随访，监测耐受性、疗效，并根据需要调整营养计划。
Safe and effective use hinges on informed practices and professional oversight. 1. Professional Guidance is Non-Negotiable Never self-prescribe. FSMP must be used under the ongoing supervision of a doctor or registered dietitian who can diagnose the nutritional deficit, select the appropriate product, and determine the dosage and duration. 2. Verify Product Legitimacy Look for clear labeling identifying it as a “Food for Special Medical Purposes” (or “medical food”) and check for compliance with relevant regional regulations (e.g., EU approval, FDA acknowledgment if in the US). Purchase from reputable sources like pharmacies or accredited home care providers. 3. Condition-Specific Selection Ensure the formula matches the specific medical condition. Using a standard formula for a condition like kidney disease can be harmful. The healthcare professional will select based on the patient’s diagnostic and lab results. 4. Adherence and Monitoring Follow preparation instructions precisely (water temperature, mixing) to ensure safety and nutrient integrity. Regular follow-ups with the healthcare provider are essential to monitor tolerance, efficacy, and adjust the nutritional plan as needed.
全球特殊医学用途配方食品（FSMP）产业的地理分布格局独特，受原材料获取、制造传统、劳动力成本和市场 proximity 等因素影响。
1. 欧洲：雀巢健康科学、达能纽迪希亚、费森尤斯卡比——监管领先。
2. 美国：雅培营养（安素、Jevity）、雀巢健康科学。
3. 日本：明治、森永、大冢制药——先进的老年营养。
4. 中国：快速增长的市场——贝因美、伊利、飞鹤正在拓展医学营养领域。
5. 澳大利亚/新西兰：在出口级婴幼儿和医学营养配方方面实力雄厚。
战略启示：在FSMP行业成功采购需要了解区域专业化，并维持多元化的采购策略，以平衡成本、质量、交货时间和地缘政治风险。可持续性认证和供应链透明度正日益成为进入高端市场的先决条件。
The global fsmp (foods for special medical purposes) industry has a distinctive geographic footprint shaped by raw material access, manufacturing heritage, labor costs, and market proximity.
1. Europe: Nestlé Health Science, Danone Nutricia, Fresenius Kabi — regulatory leadership.
2. United States: Abbott Nutrition (Ensure, Jevity), Nestlé Health Science.
3. Japan: Meiji, Morinaga, Otsuka Pharmaceutical — advanced elderly nutrition.
4. China: Rapidly growing market — Beingmate, Yili, Feihe expanding into medical nutrition.
5. Australia/New Zealand: Strong in export-quality infant and medical nutrition formulas.
Strategic Implications: Successful procurement in the fsmp (foods for special medical purposes) industry requires understanding regional specialization and maintaining diversified sourcing strategies that balance cost, quality, lead time, and geopolitical risk. Sustainability certifications and supply chain transparency are increasingly becoming prerequisites for market access in premium segments.
